Company news

Elixinol Wellness Ltd news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Strategic Review Update

March 27, 2022

FY2021 Results Presentation

February 25, 2022

FY2021 Results Announcement

February 25, 2022

FY2021 Appendix 4E

February 24, 2022

H1 FY2021 Results Presentation

August 17, 2021

H1 FY2021 Results Announcement

August 16, 2021

Termination of Proposed CannaCare Health Acquisition

June 28, 2021

EXL Presenting at Australian Micro & Small Cap Conference

June 15, 2021

Elixinol to Acquire 100% of CannaCare Health

March 17, 2021

Investor Briefing & Investor Presentation

March 15, 2021

Reinstatement to Official Quotation

March 14, 2021

Suspension from Official Quotation

March 7, 2021

FY2020 Results Announcement

February 25, 2021

Response to ASX Aware Query

December 23, 2020

Business Update

December 20, 2020

Oversubscribed Share Purchase Plan

December 15, 2020

Share Purchase Plan Update

December 3, 2020

Response to ASX Query Letter

November 19, 2020

Completion of Institutional Offer

November 15, 2020

Response to ASX Price Query (updated)

November 10, 2020

Response to ASX Price Query(updated)

November 9, 2020

Investor Briefing Video Recording

October 29, 2020

Elixinol Trading Update

September 22, 2020

H1 FY2020 Interim Report Announcement

September 14, 2020

H1 FY2020 Results ASX Announcement

August 30, 2020

Quarterly Activities Report Addendum

August 4, 2020

EXL enters into exclusive License Agreement in Japan

July 27, 2020

Hemp Foods Australia to remain with EXL

July 20, 2020

EXL Successfully Completes Retail Entitlement Offer

May 25, 2020

Despatch of Retail Entitlement Offer Booklet

May 11, 2020

Sale of Nunyara Land

May 7, 2020

Elixinol Announces Capital Raising

May 4, 2020

Elixinol Global appoints new CEO and Strengthens Board

April 21, 2020

FY2019 Investor Results Presentation

February 26, 2020

Response to ASX Appendix 4C Query Letter

February 6, 2020

Sale of HFA and Nunyara Update

February 2, 2020

Elixinol Japan Update

December 2, 2019

Quarterly Report and Appendix 4C

October 29, 2019

Market Update Elixinol Japan Operations

October 22, 2019

H1 FY2019 Results Presentation

August 28, 2019

Exclusive CBD supply agreement with Pet Releaf

August 7, 2019

Nunyara Manufacturing Licence

July 17, 2019

Leadership and Group Structure update

July 15, 2019

MedVec Distribution Agreement Signed

July 3, 2019

Strategic Partnership with RFI

June 10, 2019

Elixinol Global raises A$50m to accelerate US expansion

June 4, 2019

Elixinol acquires 25% of US based Pet Releaf

April 23, 2019

FY 2018 Investor Results Presentation

February 25, 2019

Nunyara land purchase

February 6, 2019

EXL expands into Europe driving international growth

February 5, 2019

← Newer news releases · Older news releases →

Decks

The 5 newest of 44 decks. Every deck is listed under its year.